Hisamitsu Pharmaceutical Co., Inc. (TYO:4530)
Japan flag Japan · Delayed Price · Currency is JPY
4,025.00
-23.00 (-0.57%)
Jul 30, 2025, 3:30 PM JST

Hisamitsu Pharmaceutical Co. Company Description

Hisamitsu Pharmaceutical Co., Inc. manufactures and sells pharmaceuticals in Japan.

The company provides external pain-relieving drugs under the SALONPAS, NOBINOBI, SALONSIP, AIR, SALONPAS, and FEITAS; BUTENALOCK, a remedy for athlete′s foot; and ALLEGRA FX, a sinus medication for allergies.

It also manufactures and sells quasi-drugs and cosmetics; MOHRUS TAPE and MOHRUS PAP XR, a transdermal analgesic anti-inflammatory drug; and patches for female hormone, asthma, and overactive bladders.

The company exports its products to Asia, the United States of America, and the European area. Hisamitsu Pharmaceutical Co., Inc. was founded in 1847 and is headquartered in Tosu, Japan.

Hisamitsu Pharmaceutical Co., Inc.
CountryJapan
Founded1847
IndustryDrug Manufacturers - Specialty & Generic
SectorHealthcare
Employees2,799
CEOKazuhide Nakatomi

Contact Details

Address:
Tashirodaikan-machi 408
Tosu, 841-0017
Japan
Phone81 3 5293 1720
Websiteglobal.hisamitsu

Stock Details

Ticker Symbol4530
ExchangeTokyo Stock Exchange
Stock TypeCommon Stock
Fiscal YearMarch - February
Reporting CurrencyJPY
ISIN NumberJP3784600003
SIC Code2834

Key Executives

NamePosition
Kazuhide NakatomiChief Executive Officer